FI7526U1 - Kiteinen bikalutamidi - Google Patents
Kiteinen bikalutamidiInfo
- Publication number
- FI7526U1 FI7526U1 FI20060440U FIU20060440U FI7526U1 FI 7526 U1 FI7526 U1 FI 7526U1 FI 20060440 U FI20060440 U FI 20060440U FI U20060440 U FIU20060440 U FI U20060440U FI 7526 U1 FI7526 U1 FI 7526U1
- Authority
- FI
- Finland
- Prior art keywords
- bicalutamide
- crystalline
- crystalline bicalutamide
- Prior art date
Links
- LKJPYSCBVHEWIU-KRWDZBQOSA-N (R)-bicalutamide Chemical compound C([C@@](O)(C)C(=O)NC=1C=C(C(C#N)=CC=1)C(F)(F)F)S(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-KRWDZBQOSA-N 0.000 title 1
- 229960000997 bicalutamide Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47022403P | 2003-05-14 | 2003-05-14 | |
PCT/EP2004/005189 WO2004100944A1 (en) | 2003-05-14 | 2004-05-13 | Bicalutamide forms, compositions, and processes thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
FIU20060440U0 FIU20060440U0 (fi) | 2006-10-25 |
FI7526U1 true FI7526U1 (fi) | 2007-06-12 |
Family
ID=33452382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20060440U FI7526U1 (fi) | 2003-05-14 | 2006-10-25 | Kiteinen bikalutamidi |
Country Status (9)
Country | Link |
---|---|
US (1) | US20050008691A1 (no) |
EP (1) | EP1622604A1 (no) |
JP (1) | JP2006528221A (no) |
AU (1) | AU2004238038A1 (no) |
CA (1) | CA2525318A1 (no) |
FI (1) | FI7526U1 (no) |
NO (1) | NO20055943L (no) |
WO (1) | WO2004100944A1 (no) |
ZA (1) | ZA200509152B (no) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7867516B2 (en) | 2001-01-29 | 2011-01-11 | Shionogi & Co., Ltd. | Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient |
US20040063782A1 (en) * | 2002-09-27 | 2004-04-01 | Westheim Raymond J.H. | Bicalutamide forms |
KR101185662B1 (ko) * | 2004-07-14 | 2012-09-24 | 스미또모 가가꾸 가부시키가이샤 | 비칼루타미드의 결정 석출 방법 |
AU2005329762A1 (en) * | 2005-03-29 | 2006-10-05 | Usv Limited | Process for preparation of bicalutamide |
US7785629B2 (en) | 2005-06-21 | 2010-08-31 | Helm Ag | Bicalutamide-adsorbates, process for preparing same, and pharmaceutical compositions thereof |
CA2614468A1 (en) * | 2005-07-15 | 2007-01-25 | Teva Pharmaceutical Industries Ltd. | Novel granulation process and granulate produced therefrom |
US20070014853A1 (en) * | 2005-07-15 | 2007-01-18 | Ilan Zalit | Pharmaceutical dosage form containing novel pharmaceutical granulate |
US20070014854A1 (en) * | 2005-07-15 | 2007-01-18 | Ilan Zalit | Novel granulation process |
US20070014864A1 (en) * | 2005-07-15 | 2007-01-18 | Teva Pharmaceutical Industries, Ltd. | Novel pharmaceutical granulate |
JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
NZ591443A (en) * | 2005-09-22 | 2013-04-26 | Intermune Inc | Granule formation of pirfenidone and pharmaceutically acceptable excipients |
CZ299577B6 (cs) * | 2005-12-20 | 2008-09-03 | Interpharma Praha, A. S. | Zpusob výroby vysoce cistého 4-kyano-3-trifluoromethyl-N-(3-p-fluorfenylsulfonyl-2-hydroxy-2-methylpropionyl) anilinu |
US20070148245A1 (en) * | 2005-12-22 | 2007-06-28 | Ilan Zalit | Compressed solid dosage forms with drugs of low solubility and process for making the same |
WO2007104034A2 (en) | 2006-03-08 | 2007-09-13 | Takeda San Diego, Inc. | Glucokinase activators |
EP2049518B1 (en) | 2006-05-31 | 2011-08-31 | Takeda San Diego, Inc. | Indazole and isoindole derivatives as glucokinase activating agents. |
EP2046321A4 (en) * | 2006-07-07 | 2011-08-31 | Panacea Biotec Ltd | PHARMACEUTICAL COMPOSITION COMPRISING BICALUTAMIDE AND METHOD FOR USE THEREOF |
US20080045600A1 (en) * | 2006-08-17 | 2008-02-21 | Gawande Rahul S | Bicalutamide compositions |
US20100034888A1 (en) * | 2006-09-15 | 2010-02-11 | Hubert Clemens Pellikaan | Granulate containing a pharmaceutically active substance and method for its manufacture |
ES2536922T3 (es) * | 2006-09-15 | 2015-05-29 | Echo Pharmaceuticals B.V. | Unidad de dosificación para administración sublingual, bucal u oral de sustancias farmacéuticamente activas insolubles en agua |
US8163779B2 (en) | 2006-12-20 | 2012-04-24 | Takeda San Diego, Inc. | Glucokinase activators |
GB0702826D0 (en) * | 2007-02-14 | 2007-03-28 | Pliva Istrazivanje I Razvoj D | Preparation and composition of solid dosage form containing Bicalutamide |
WO2008116107A2 (en) | 2007-03-21 | 2008-09-25 | Takeda San Diego, Inc. | Piperazine derivatives as glucokinase activators |
JP5714492B2 (ja) * | 2008-09-17 | 2015-05-07 | マイラン インコーポレイテッド | 粒状体、それらの調製方法、およびそれらを含む医薬品 |
CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
EP3615032A4 (en) | 2017-04-28 | 2020-12-23 | Asana BioSciences, LLC | FORMULATIONS, PROCEDURES, KITS AND DOSING FORMS FOR TREATMENT OF ATOPIC DERMATITIS AND IMPROVED STABILITY OF AN ACTIVE INGREDIENT |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3372965D1 (en) * | 1982-07-23 | 1987-09-17 | Ici Plc | Amide derivatives |
ES2060737T3 (es) * | 1988-02-25 | 1994-12-01 | Yamanouchi Europ Bv | Procedimiento de preparacion de un granulado farmaceutico. |
FR2684298B1 (fr) * | 1991-12-03 | 1994-03-11 | Rhone Poulenc Rorer Sa | Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4. |
WO1995019770A1 (en) * | 1994-01-21 | 1995-07-27 | Sepracor, Inc. | Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex |
US6019957A (en) * | 1997-06-04 | 2000-02-01 | The University Of Tennessee Research Corporation | Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging |
HU223950B1 (hu) | 1999-06-10 | 2005-03-29 | Richter Gedeon Vegyészeti Gyár Rt. | Eljárás a racém, valamint az R-(-)- és S-(+)-N-[4-ciano-3-(trifluor-metil)-fenil]-3-[(4-fluor-fenil)-szulfonil]-2-hidroxi-2-metil-propánsavamid előállítására |
CN1503662A (zh) * | 2001-02-27 | 2004-06-09 | 药物制剂 | |
HUP0303454A3 (en) * | 2001-04-02 | 2005-12-28 | Astrazeneca Ab | Solid pharmaceutical composition comprising 4-cyano-trifluoro-3(4-fluorophenyl-sulphonyl)-2-hydroxy-2-methylpropiono-m toluidide and pvp |
US6458769B1 (en) * | 2001-06-25 | 2002-10-01 | Astrazeneca Ab | Amorphous compound |
SE0103838D0 (sv) * | 2001-11-16 | 2001-11-16 | Astrazeneca Ab | Pharmaceutical formulation & product |
GB0216700D0 (en) * | 2002-07-18 | 2002-08-28 | Astrazeneca Ab | Process |
US20040063782A1 (en) * | 2002-09-27 | 2004-04-01 | Westheim Raymond J.H. | Bicalutamide forms |
-
2004
- 2004-05-11 US US10/842,632 patent/US20050008691A1/en not_active Abandoned
- 2004-05-13 WO PCT/EP2004/005189 patent/WO2004100944A1/en active Search and Examination
- 2004-05-13 EP EP04732612A patent/EP1622604A1/en not_active Withdrawn
- 2004-05-13 JP JP2006529819A patent/JP2006528221A/ja not_active Withdrawn
- 2004-05-13 CA CA002525318A patent/CA2525318A1/en not_active Abandoned
- 2004-05-13 AU AU2004238038A patent/AU2004238038A1/en not_active Abandoned
-
2005
- 2005-11-11 ZA ZA200509152A patent/ZA200509152B/en unknown
- 2005-12-14 NO NO20055943A patent/NO20055943L/no not_active Application Discontinuation
-
2006
- 2006-10-25 FI FI20060440U patent/FI7526U1/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ZA200509152B (en) | 2007-04-25 |
EP1622604A1 (en) | 2006-02-08 |
NO20055943L (no) | 2006-01-25 |
AU2004238038A1 (en) | 2004-11-25 |
CA2525318A1 (en) | 2004-11-25 |
US20050008691A1 (en) | 2005-01-13 |
FIU20060440U0 (fi) | 2006-10-25 |
WO2004100944A1 (en) | 2004-11-25 |
JP2006528221A (ja) | 2006-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI7526U1 (fi) | Kiteinen bikalutamidi | |
SE0301569D0 (sv) | Novel compounds | |
DK1605897T3 (da) | Polyethelen-glycol-link-glp-1-forbindelser | |
IS8108A (is) | Ný efnasambönd | |
ATE368042T1 (de) | Cephemverbindungen | |
ATE383329T1 (de) | Biaryloxymethylarenecarbonsäure | |
IS8228A (is) | Ný asetídínefnasambönd | |
IS8089A (is) | Efnasambönd | |
IS7381A (is) | Efnasambönd | |
IS8292A (is) | Ný efnasambönd | |
IS7414A (is) | Oxó-azabísýklísk efnasambönd | |
NO20055097D0 (no) | Krystallinske N-formyl-hydroksylaminforbindelser | |
DK1633719T3 (da) | Substituerede spirobenzazepiner | |
DE502004009935D1 (de) | Substituierte dihydrochinazoline ii | |
DE502004007017D1 (de) | Zwischenfestlegung | |
NO20031736D0 (no) | Forbindelser | |
SE0303452D0 (sv) | New compounds | |
NO20044364L (no) | Hydroksykarbamimidoyl-2-hydroksy-benzensulfonamidderivat-krystaller | |
SE0203348D0 (sv) | Novel compounds | |
SE0302667D0 (sv) | Novel Compounds | |
SE0300118D0 (sv) | Novel Compounds | |
SE0300388D0 (sv) | Novel compounds | |
NO20035294D0 (no) | Forbindelser | |
NO20030117D0 (no) | Forbindelser | |
NO20033173D0 (no) | Forbindelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGU | Utility model registered |
Ref document number: 7526 Country of ref document: FI |
|
MAU | Utility model expired |